SINGAPORE HEALTH SERVICES PTE. LTD.;AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH;TESSA THERAPEUTICS LTD.
发明人:
申请号：
PT16871163
公开号：
PT3384052T
申请日:
2016.09.09
申请国别(地区):
PT
年份:
2020
代理人:
摘要：
A method for predicting whether a patient will be a long-term survivor on treatment of a disease by adoptive cell transfer (ACT), is disclosed comprising: (i) analyzing a blood-derived sample obtained from the patient for one or more prognostic markers of long-term survival on treatment of a disease by ACT, and； (ii) based on the analysis of step (i), predicting whether the patient will be a long-term survivor on treatment of the disease by ACT. Also disclosed are methods for treating a patient by ACT, methods for selecting a patient for treatment by ACT, and methods for selecting a patient for treatment of a disease by ACT.
